Drawing for EMSA + CHS

USPTO serial 74290259

EMSA + CHS

Reviewed by CopyMark Law Group

Status 601
Filing date
Status date
Registration date
—
Examiner
CLARK, ROBERT C
Law office
FILE REPOSITORY (FRANCONIA)

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with EMSA + CHS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Barry L. Haley

BARRY L HALEY MALIN, HALEY, MCHALE, DIMAGGIO & CROSBYSTE 1609ONE E BROWARD BLVDFT LAUDERDALE, FL 33301

Goods and services

ClassDescriptionStatusFirst use
042in-hospital pediatric health care servicesABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 20, 1995ABN1ABANDONMENT - EXPRESS MAILED—
Aug 31, 1994CNSLLETTER OF SUSPENSION MAILED—
Jul 8, 1993CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Apr 19, 1993CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 14, 1992CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 3, 1992DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance